The embryonic high mobility group AT-hook 2 (HMGA2), a direct target of let-7 (51–53), is a non-histone, nuclear-binding, oncofetal protein that has been shown to be overexpressed in embryonic tissue and many malignancies, including high-grade ovarian carcinomas (54, 55). The gene discussed is HMGA2; the disease is ovarian carcinoma.